NCT04814927View on ClinicalTrials.gov

Impact of Contraceptives on Cervico-Vaginal Mucosa

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 15, 2022

Study Completion Date

December 15, 2022

Conditions
Mucosal InflammationContraceptive; Complications, Intrauterine
Interventions
DRUG

Copper IUD

Participants randomized to Copper IUD will receive Paragard IUD at Visit 2.

DRUG

Etonogestrel implant

Participants randomized to ETG implant will receive the implant at Visit 2.

DRUG

Levonorgestrel IUS

Participants randomized to LNG intrauterine system will receive the IUS at Visit 2.

DRUG

DMPA Sub-cutaneous

Participants randomized to DMPA SC will receive the injection at Visit 2.

Trial Locations (2)

23507

Eastern Virginia Medical School, Norfolk

01000

KEMRI, Thika

Sponsors
All Listed Sponsors
collaborator

CONRAD

OTHER

collaborator

Kenya Medical Research Institute

OTHER

collaborator

United States Agency for International Development (USAID)

FED

lead

Eastern Virginia Medical School

OTHER